Avalon Pharmaceuticals to Present at BIO InvestorForum 2006
October 16 2006 - 7:00AM
PR Newswire (US)
GERMANTOWN, Md., Oct. 16 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX), a
biopharmaceutical company focused on the discovery and development
of small molecule therapeutics, today announced that Kenneth C.
Carter, Ph.D., President and CEO, is scheduled to provide an update
on the Company at the BIO InvestorForum 2006. The conference will
be held at the Palace Hotel in San Francisco, CA on October 17-19,
2006 and Dr. Carter is scheduled to present on Wednesday, October
18th at 2 p.m., PDT, in the Presidio Room. A live audio webcast of
this presentation can be accessed on Avalon Pharmaceuticals'
website, http://www.avalonrx.com/. A replay of the presentation
will also be available for 90 days after the conference. About
Avalon Pharmaceuticals Avalon Pharmaceuticals is a
biopharmaceutical company focused on the discovery and development
of small molecule therapeutics through the use of a comprehensive,
innovative and proprietary suite of technologies based upon
large-scale gene expression analysis which it calls AvalonRx(R).
This platform facilitates drug discovery by expanding the range of
therapeutic targets for drug intervention, including targets and
target pathways frequently considered intractable using
conventional HTS approaches, allows more informed decisions about
which compounds to advance towards clinical trials, and facilitates
drug development through identification of biomarkers of efficacy
that can stratify patients or provide early indicators of response.
Avalon's focus is oncology but the company has discovery programs
in other therapeutic areas with partners. Avalon Pharmaceuticals
was established in 1999 and is headquartered in Germantown,
Maryland. Contacts: Avalon Pharmaceuticals, Inc. Noonan Russo Gary
Lessing Wendy Lau (Media) Executive Vice President & CFO Tel:
(212) 845-4272 Tel: (301) 556-9900 Fax: (301) 556-9910 The Trout
Group LLC Email: Chad Rubin (Investors) Tel: (212) 477-9007 ext. 47
DATASOURCE: Avalon Pharmaceuticals, Inc. CONTACT: Gary Lessing,
Executive Vice President & CFO, Avalon Pharmaceuticals, Inc.,
+1-301-556-9900, ; Media: Wendy Lau of Noonan Russo,
+1-212-845-4272; Investors: Chad Rubin of The Trout Group LLC,
+1-212-477-9007 ext. 47 Web site: http://www.avalonrx.com/
Copyright